Tag: MTNB

  • Matinas BioPharma Holdings Inc. (MTNB) Rises After Hours Thanks to Programs Update and 2022 Outlook

    On January 25, Matinas BioPharma Holdings Inc. (MTNB) provided an ongoing program update along with the outlook for 2022. Consequently, the stock became bullish in the after hours.

    During the regular trading session, MTNB suffered a loss of 16.22% at its close of $0.67. Following the announcement, the stock rebounded to add 7.42% in the after-hours. Hence, MNTB was trading at $0.72 per share at an after-hours volume of 146.37K, on Tuesday.

    The clinical-stage biopharmaceutical company, Matinas BioPharma Holdings Inc. has a market capitalization of $172.93 million. Currently, it has 216.25 million shares outstanding in the market.

    Program Updates and Milestones

    The key updates and upcoming milestones of MTNB’s programs include:

    MAT2203 Program

    • Positive meeting with FDA in December 2021.
    • CMC meeting with FDA in late Q1 2022 with expectations for late 2023 NDA submission.
    • FDA meetup in Q2 2022 for expansion details of Cohort 5 of EnACT trial.
    • Commencement of Cohort 4 EnACT with preliminary data expectation in Q3 2022.
    • Data from additional preclinical studies is expected in late 2022.
    • Request for Scientific Advice submission to EMA in Q2 of 2022.

    LNC Platform

    • Collaboration with National Institute of Allergy and Infectious Diseases (NIAID) along with Department of Epidemiology at UNC. Moreover, the initiation of the preclinical collaborative trial is estimated in Q1 and data in the second half of 2022.
    • Extension of collaboration with Genentech, with additional data expected in 2022.

    MAT2501 Program

    • Data from ongoing SAD Mat2501 anticipated in Q2 2022.
    • Additional grant award by Cystic Fibrosis Foundation (CFF) in Q4 of 2021, hence totaling $4.5 million for MAT2501.
    • Long-term preclinical toxicology studies are intended in 2022.
    • Phase 2 trial underworks with initiation expected in 2023 awaiting CFF support.

    LYPDISOTM Program

    Interest from various companies, with evaluation for partnership ongoing and update expected in Q2 2022.

    MTNB’s Future Outlook

    According to the preliminary, unaudited estimate, MTNB had cash, cash equivalents, and marketable securities of $49.9M approx., on December 31, 2021. Comparatively, the same was $58.7M the year before.

    Thus, as per the company’s projections, MTNB expects the current cash position to lead the company’s operations into 2023.

    MTNB’s Q3 Financial Highlight

    In the third quarter of 2021, the company incurred a net loss of $6.8, against $5.7 million in Q3 of 2020. Resultantly, the net loss per basic and diluted share was $0.03 in Q3 of 2021 and 2020.

  • Pre-Market Cues: 29 Stocks Roaring for Change On December 7th

    Pre-Market Cues: 29 Stocks Roaring for Change On December 7th

    HL Acquisitions Corp. (HCCH) is up more than 5.38% at $25.25 in pre-market hours Monday December 07, 2020. The firm recently reported that that the shareholders of HL have approved the business combination between HL and Fusion Fuel at an annual general meeting of shareholders. The stock had jumped over 27.65% to $23.96 in the last trading session.
    China HGS Real Estate Inc. (NASDAQ: HGSH) shares are trading down -17.83% at $2.12 at the time of writing. Company’s 52-week ranged between $0.48 to $4.40.
    Cinedigm Corp. (CIDM) grew over 4.07% at $0.7269 in pre-market trading today after announcing eight additional linear streaming channels are now available on Rad’s fast-growing global streaming platform.
    Before the trading started on December 07, 2020, PDS Biotechnology Corporation (PDSB) is down -7.49% to reach $2.47. It has been trading in a 52-week range of $0.62 to $4.98.
    Pioneer Power Solutions Inc. (PPSI), a Electrical Equipment & Parts company, dropped about -6.59% at $4.11 in pre-market trading Monday. The company lately declared that it has finalized a conclusive settlement with Myers Power Products, Inc., a specialty electrical products manufacturer.
    Castor Maritime Inc. (NASDAQ: CTRM) shares are trading down -3.25% at $0.1935 at the time of writing. Company’s 52-week ranged between $0.11 to $2.60.
    RMG Acquisition Corp. (RMG) is down more than -5.62% at $17.31 in pre-market hours Monday December 07, 2020. The firm recently announced the nomination of Paul Williams to serve on the board of directors of Romeo Power upon consummation of merger. The stock had jumped over 19.95% to $18.34 in the last trading session.
    Before the trading started on December 07, 2020, Energy Fuels Inc. (UUUU) is up 6.2% to reach $2.74. It has been trading in a 52-week range of $0.78 to $2.42.
    Safe-T Group Ltd (SFET) stock soared 20.49% to $1.47 in the pre-market trading. The technology firm recently declared that it will hold a virtual event – webinar with Fujitsu, a global information and communication technology (ICT) company, on December 10, 2020.
    Before the trading started on December 07, 2020, ENGlobal Corporation (ENG) is up 4.42% to reach $1.89. It has been trading in a 52-week range of $0.46 to $4.32.
    Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) shares are trading down -6.96% at $1.47 at the time of writing after reporting that it will provide its QuadSight® multispectral vision solution, and is expected to receive approximately one million USD from the European Commission through the Horizon 2020 framework program. Company’s 52-week ranged between $0.46 to $1.95. Analysts have a consensus price target of $16.
    Hennessy Capital Acquisition Corp. IV (HCAC) is up more than 16.13% at $15.62 in pre-market hours Monday December 07, 2020. The stock had jumped over 10.52% to $13.45 in the last trading session.
    Sesen Bio Inc. (SESN) is up more than 4.58% at $1.6 in pre-market hours Monday December 07, 2020. The firm recently revealed partnership with Hikma Pharmaceuticals for the commercialization of Vicineum™ in the Middle East and North Africa. The stock had jumped over 15.04% to $1.53 in the last trading session.
    Before the trading started on December 07, 2020, Apache Corporation (APA) is down -2.5% to reach $14.8. It has been trading in a 52-week range of $3.80 to $33.77.
    BlackBerry Limited (NYSE: BB) shares are trading down -2.7% at $8.29 at the time of writing after declaring that it will report results for the third quarter of fiscal year 2021 at 5:30 p.m. ET on Thursday, December 17, 2020. Company’s 52-week ranged between $2.70 to $9.69.
    TechnipFMC plc (NYSE: FTI) shares are trading down -3.41% at $9.92 at the time of writing. Company’s 52-week ranged between $4.49 to $21.84.
    Nesco Holdings Inc. (NSCO) tumbled over -12.41% at $5.86 in pre-market trading today as the firm revealed that it has entered into a definitive agreement to acquire Custom Truck One Source (“CTOS”) for a purchase price of $1.475 billion.
    Penn Virginia Corporation (PVAC) is down more than -2.05% at $9.55 in pre-market hours Monday December 07, 2020. The stock had jumped over 7.50% to $9.75 in the last trading session.
    Uranium Energy Corp. (UEC) stock soared 11.57% to $1.35 in the pre-market trading after reporting that the U.S. Senate Committee on Environment and Public Works (EPW) has approved a bipartisan bill entitled the American Nuclear Infrastructure Act (ANIA). The most recent rating by Canaccord Genuity, on October 14, 2020, is a Speculative buy.
    Lyft Inc. (NASDAQ: LYFT) shares are trading up 2.67% at $47.33 at the time of writing. Company’s 52-week ranged between $14.56 to $54.50.
    Verb Technology Company Inc. (VERB) grew over 2.46% at $1.25 in pre-market trading today. The firm lately revealed that it will deliver a presentation at the Benzinga Global Small Cap Conference being held December 8-9, 2020.
    TransEnterix Inc. (TRXC) is down more than -7.22% at $0.47 in pre-market hours Monday December 07, 2020. The stock had jumped over 6.63% to $0.51 in the last trading session.
    FuelCell Energy Inc. (FCEL), a Electrical Equipment & Parts company, rose about 3.77% at $8.25 in pre-market trading Monday following the closing of public offering of 39,696,320 shares of common stock.
    Before the trading started on December 07, 2020, Senseonics Holdings Inc. (SENS) is up 9.28% to reach $0.4699. It has been trading in a 52-week range of $0.35 to $1.78.
    Before the trading started on December 07, 2020, The Macerich Company (MAC) is down -2.44% to reach $11.6 after declaring that the Company has earned Bureau Veritas SafeGuard™ Hygiene Excellence and Safety Certification for key properties. It has been trading in a 52-week range of $4.56 to $26.20.
    Southwestern Energy Company (SWN) stock plunged -2.33% to $2.93 in the pre-market trading. The most recent rating by UBS, on December 01, 2020, is a Sell.
    Gamida Cell Ltd. (GMDA) is up more than 7.6% at $7.5 in pre-market hours Monday December 07, 2020 after reporting in an oral presentation the updated and expanded results from a Phase 1 clinical study of GDA-201. The stock had jumped over 5.61% to $6.97 in the last trading session.
    Sintx Technologies Inc. (NASDAQ: SINT) shares are trading up 2.45% at $2.09 at the time of writing. Company’s 52-week ranged between $0.28 to $3.30.
    Matinas BioPharma Holdings Inc. (MTNB) grew over 12.84% at $1.23 in pre-market trading today after announcing collaboration with the National Institute of Allergy and Infectious Diseases to evaluate oral formulations of Gilead’s antiviral remdesivir utilizing Matinas’ LNC Platform delivery technology.

  • 15 Trending Stocks in Biotechnology Industry

    15 Trending Stocks in Biotechnology Industry

    The biggest movers of the 2020 are biotech stocks. Now, the COVID-19 pandemic has put brighter spotlight on the future of healthcare and specially biotech stocks have respond accordingly.

    Innovative biotech business have adopted the change and are competing to make what could become a life-saving treatment for millions in the form of a vaccine.

    Some of the biggest winners of this transformative mega-trend are discussed below.

    Genocea Biosciences Inc. (NASDAQ:GNCA) shares were trading up 24.44% at $4.48 at the time of writing on Friday.

    Genocea Biosciences Inc. (NASDAQ:GNCA) share price went from a low point around $1.10 to briefly over $3.86 in past 52 weeks, though shares have since pulled back to $4.48. GNCA market cap has remained high, hitting $99.50M at the time of writing, giving it price-to-sales ratio of more than 110.

    If we look at the recent analyst rating GNCA, SVB Leerink initiated coverage on GNCA shares with an Outperform.

    Arbutus Biopharma Corporation (ABUS) last closed at $4.96, in a 52-week range of $0.82 to $6.48. Analysts have a consensus price target of $5.00.

    Ocugen Inc. (OCGN) stock soar by 32.85% to $0.38.

    Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Shares headed falling, lower as much as -3.97%. The most recent rating by ROTH Capital, on April 18, 2019, is at a Buy.

    Capricor Therapeutics Inc. (NASDAQ:CAPR) rose 29.31% after gaining more than $1.75 on Friday.

    Ampio Pharmaceuticals Inc. (AMPE) last closed at $0.96, in a 52-week range of $0.26 to $0.97.

    iBio Inc. (IBIO) last closed at $5.50, in a 52-week range of $0.05 to $7.45.

    Novan Inc. (NOVN) stock soar by 6.06% to $0.86. The most recent rating by Piper Jaffray, on January 06, 2020, is at a Neutral.

    Onconova Therapeutics Inc. (NASDAQ:ONTX) Shares headed falling, lower as much as -2.63%. The most recent rating by H.C. Wainwright, on March 01, 2018, is at a Buy.

    Actinium Pharmaceuticals Inc. (AMEX:ATNM) rose 7.45% after gaining more than $0.03 on Friday.

    Sesen Bio Inc. (SESN) last closed at $0.99, in a 52-week range of $0.37 to $1.54.

    VistaGen Therapeutics Inc. (VTGN) stock drop by -4.39% to $0.76. The most recent rating by Maxim Group, on June 27, 2018, is at a Buy.

    Qualigen Therapeutics Inc. (NASDAQ:QLGN) Shares headed rising, higher as much as 11.22%.

    PolarityTE Inc. (NASDAQ:PTE) rose 10.56% after gaining more than $0.17 on Friday.

    Matinas BioPharma Holdings Inc. (MTNB) last closed at $0.96, in a 52-week range of $0.49 to $2.49.